Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_assertion type Assertion NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_head.
- NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_assertion description "[We analyzed erythroid response to erythropoetin (EPO) or darbepoetin (DAR) and thalidomide in MDS with 5q deletion treated by French centers (GFM) and in whom karyotype was successfully performed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_provenance.
- NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_assertion evidence source_evidence_literature NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_provenance.
- NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_assertion SIO_000772 18191202 NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_provenance.
- NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_assertion wasDerivedFrom befree-20140225 NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_provenance.
- NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_assertion wasGeneratedBy ECO_0000203 NP649947.RAwtEKEBQRLaV9lYRuRFGcLn0KKmG9DOBgH0enUniGarU130_provenance.